Search research articles
Contact Us
Filters
Showing results (101-110 of 234) with videos related to
Page
of 24
Sort By:
Journal of Cosmetic Dermatology
|
September 18, 2024
Real-World Experience Using a Multi-Modality System using Intense Pulsed Light, Radiofrequency Microneedling, High-Intensity Focused Ultrasound, or Thermal Radiofrequency, 808, HIFU for Skin Rejuvenation Treatment
Michael Gold, Brian Biesman, Joel L Cohen, et al.
Journal of Drugs in Dermatology : JDD
|
January 11, 2024
Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis
Michael Gold, Anneke Andriessen, Cheryl Burgess, et al.
Journal of Cosmetic Dermatology
|
February 13, 2024
A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalization
David J Goldberg, Anneke Andriessen, Michael Gold, et al.
Dementia and Geriatric Cognitive Disorders
|
July 2, 2005
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
Henry Brodaty, Jody Corey-Bloom, Felix C V Potocnik, et al.
Journal of Drugs in Dermatology : JDD
|
November 16, 2020
Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne
Leon H Kircik, Edward Lain, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD
|
August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris
Joel Schlessinger, Alan Menter, Michael Gold, et al.
International Journal of Geriatric Psychiatry
|
September 28, 2010
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
Gareth Maher-Edwards, Ruth Dixon, Jackie Hunter, et al.
Annals of Neurology
|
July 23, 2025
Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis
Bruce A C Cree, Mark S Freedman, Michael Gold, et al.
Journal of Cosmetic Dermatology
|
August 23, 2024
"Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults-A systematic review"
Vaibhav Kumar, Michael Gold, Anuj Jain, et al.
Journal of the American Society of Cytopathology
|
May 3, 2019
Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas
Rachel Conrad, Nicolas Wentzensen, Roy R Zhang, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 234) with videos related to
Sort By:
Page
of 24
Journal of Cosmetic Dermatology
|
September 18, 2024
Real-World Experience Using a Multi-Modality System using Intense Pulsed Light, Radiofrequency Microneedling, High-Intensity Focused Ultrasound, or Thermal Radiofrequency, 808, HIFU for Skin Rejuvenation Treatment
Michael Gold, Brian Biesman, Joel L Cohen, et al.
Journal of Drugs in Dermatology : JDD
|
January 11, 2024
Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis
Michael Gold, Anneke Andriessen, Cheryl Burgess, et al.
Journal of Cosmetic Dermatology
|
February 13, 2024
A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalization
David J Goldberg, Anneke Andriessen, Michael Gold, et al.
Dementia and Geriatric Cognitive Disorders
|
July 2, 2005
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
Henry Brodaty, Jody Corey-Bloom, Felix C V Potocnik, et al.
Journal of Drugs in Dermatology : JDD
|
November 16, 2020
Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne
Leon H Kircik, Edward Lain, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD
|
August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris
Joel Schlessinger, Alan Menter, Michael Gold, et al.
International Journal of Geriatric Psychiatry
|
September 28, 2010
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
Gareth Maher-Edwards, Ruth Dixon, Jackie Hunter, et al.
Annals of Neurology
|
July 23, 2025
Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis
Bruce A C Cree, Mark S Freedman, Michael Gold, et al.
Journal of Cosmetic Dermatology
|
August 23, 2024
"Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults-A systematic review"
Vaibhav Kumar, Michael Gold, Anuj Jain, et al.
Journal of the American Society of Cytopathology
|
May 3, 2019
Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas
Rachel Conrad, Nicolas Wentzensen, Roy R Zhang, et al.
Page
of 24